Literature DB >> 21663442

Genetics of speech and language disorders.

Changsoo Kang1, Dennis Drayna.   

Abstract

Vocal communication mediated by speech and language is a uniquely human trait, and has served an important evolutionary role in the development of our species. Deficits in speech and language functions can be of numerous types, including aphasia, stuttering, articulation disorders, verbal dyspraxia, and specific language impairment; language deficits are also related to dyslexia. Most communication disorders are prominent in children, where they are common. A number of these disorders have been shown to cluster in families, suggesting that genetic factors are involved, but their etiology at the molecular level is not well understood. In the past decade, genetic methods have proven to be powerful for understanding these etiologies. Linkage studies and molecular genetic analyses in a large family containing multiple individuals affected with verbal dyspraxia led to the discovery of mutations in the FOXP2 gene. This gene encodes a forkhead domain transcription factor, a finding that has led researchers to a new avenue of investigation into the substrates and mechanisms that underlie human speech development. In studies of stuttering, linkage and candidate gene approaches in consanguineous families identified mutations in the lysosomal enzyme-targeting pathway genes GNPTAB, GNPTG, and NAGPA, revealing a role for inherited defects in cell metabolism in this disorder. In specific language impairment, linkage studies have identified several loci, and candidate gene association studies are making progress in identifying causal variants at these loci. Although only a small fraction of all cases of speech and language disorders can be explained by genetic findings to date, the significant progress made thus far suggests that genetic approaches will continue to provide important avenues for research on this group of disorders.

Entities:  

Mesh:

Year:  2011        PMID: 21663442     DOI: 10.1146/annurev-genom-090810-183119

Source DB:  PubMed          Journal:  Annu Rev Genomics Hum Genet        ISSN: 1527-8204            Impact factor:   8.929


  23 in total

1.  PKNOX2 is associated with formal thought disorder in schizophrenia: a meta-analysis of two genome-wide association studies.

Authors:  Ke-Sheng Wang; Qunyuan Zhang; Xuefeng Liu; Longyang Wu; Min Zeng
Journal:  J Mol Neurosci       Date:  2012-05-31       Impact factor: 3.444

Review 2.  Golgi post-translational modifications and associated diseases.

Authors:  Sven Potelle; André Klein; François Foulquier
Journal:  J Inherit Metab Dis       Date:  2015-05-13       Impact factor: 4.982

3.  Heterozygous deletion of the LRFN2 gene is associated with working memory deficits.

Authors:  Julien Thevenon; Céline Souchay; Gail K Seabold; Inna Dygai-Cochet; Patrick Callier; Sébastien Gay; Lucie Corbin; Laurence Duplomb; Christel Thauvin-Robinet; Alice Masurel-Paulet; Salima El Chehadeh; Magali Avila; Delphine Minot; Eric Guedj; Sophie Chancenotte; Marlène Bonnet; Daphne Lehalle; Ya-Xian Wang; Paul Kuentz; Frédéric Huet; Anne-Laure Mosca-Boidron; Nathalie Marle; Ronald S Petralia; Laurence Faivre
Journal:  Eur J Hum Genet       Date:  2015-10-21       Impact factor: 4.246

4.  Studies in a consanguineous family reveal a novel locus for stuttering on chromosome 16q.

Authors:  Muhammad Hashim Raza; Rana Amjad; Sheikh Riazuddin; Dennis Drayna
Journal:  Hum Genet       Date:  2011-12-29       Impact factor: 4.132

Review 5.  Insights into the genetic foundations of human communication.

Authors:  Sarah A Graham; Pelagia Deriziotis; Simon E Fisher
Journal:  Neuropsychol Rev       Date:  2015-01-18       Impact factor: 7.444

Review 6.  Pre-clinical models of neurodevelopmental disorders: focus on the cerebellum.

Authors:  Alexey V Shevelkin; Chinezimuzo Ihenatu; Mikhail V Pletnikov
Journal:  Rev Neurosci       Date:  2014       Impact factor: 4.353

7.  TM4SF20 ancestral deletion and susceptibility to a pediatric disorder of early language delay and cerebral white matter hyperintensities.

Authors:  Wojciech Wiszniewski; Jill V Hunter; Neil A Hanchard; Jason R Willer; Chad Shaw; Qi Tian; Anna Illner; Xueqing Wang; Sau W Cheung; Ankita Patel; Ian M Campbell; Violet Gelowani; Patricia Hixson; Audrey R Ester; Mahshid S Azamian; Lorraine Potocki; Gladys Zapata; Patricia P Hernandez; Melissa B Ramocki; Regie L P Santos-Cortez; Gao Wang; Michele K York; Monica J Justice; Zili D Chu; Patricia I Bader; Lisa Omo-Griffith; Nirupama S Madduri; Gunter Scharer; Heather P Crawford; Pattamawadee Yanatatsaneejit; Anna Eifert; Jeffery Kerr; Carlos A Bacino; Adiaha I A Franklin; Robin P Goin-Kochel; Gayle Simpson; Ladonna Immken; Muhammad E Haque; Marija Stosic; Misti D Williams; Thomas M Morgan; Sumit Pruthi; Reed Omary; Simeon A Boyadjiev; Kay K Win; Aye Thida; Matthew Hurles; Martin Lloyd Hibberd; Chiea Chuen Khor; Nguyen Van Vinh Chau; Thomas E Gallagher; Apiwat Mutirangura; Pawel Stankiewicz; Arthur L Beaudet; Mirjana Maletic-Savatic; Jill A Rosenfeld; Lisa G Shaffer; Erica E Davis; John W Belmont; Sarah Dunstan; Cameron P Simmons; Penelope E Bonnen; Suzanne M Leal; Nicholas Katsanis; James R Lupski; Seema R Lalani
Journal:  Am J Hum Genet       Date:  2013-06-27       Impact factor: 11.025

8.  An informatics approach to integrating genetic and neurological data in speech and language neuroscience.

Authors:  Jason W Bohland; Emma M Myers; Esther Kim
Journal:  Neuroinformatics       Date:  2014-01

Review 9.  Putative miRNAs for the diagnosis of dyslexia, dyspraxia, and specific language impairment.

Authors:  Alexander Rudov; Marco Bruno Luigi Rocchi; Augusto Accorsi; Giorgio Spada; Antonio Domenico Procopio; Fabiola Olivieri; Maria Rita Rippo; Maria Cristina Albertini
Journal:  Epigenetics       Date:  2013-08-15       Impact factor: 4.528

10.  Expression of FoxP2 in the basal ganglia regulates vocal motor sequences in the adult songbird.

Authors:  Lei Xiao; Devin P Merullo; Therese M I Koch; Mou Cao; Marissa Co; Ashwinikumar Kulkarni; Genevieve Konopka; Todd F Roberts
Journal:  Nat Commun       Date:  2021-05-11       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.